Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging

Triple-negative breast cancer (TNBC) does not express estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. Because TNBC lacks the expression of commonly targeted receptors, it is challenging to develop a new imaging agent for this cancer subtype. Heterogeneous nucl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Abhinav Bhise, Hyun Park, Woonghee Lee, Swarbhanu Sarkar, Yeong Su Ha, Subramani Rajkumar, Bora Nam, Jeong Eun Lim, Phuong Tu Huynh, Kiwoong Lee, Ji-Yoon Son, Jung Young Kim, Kyo Chul Lee, Jeongsoo Yoo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-08-01
Colecção:	Pharmaceutics
Assuntos:	hnRNPA2B1 immuno-PET pretargeting triple-negative breast cancer nuclear imaging
Acesso em linha:	https://www.mdpi.com/1999-4923/14/8/1677
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!